Giuliano La Fratta
Director of Finance/CFO bei AETERNA ZENTARIS INC.
Vermögen: - $ am 30.04.2024
Profil
Giuliano La Fratta is currently the Chief Financial Officer & Senior Vice President at Æterna Zentaris, Inc. Prior to this, he was the Vice President-Finance at CellCarta Biosciences, Inc. He obtained his undergraduate degree from Concordia University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
AETERNA ZENTARIS INC.
-.--% | 12.01.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Giuliano La Fratta
Unternehmen | Position | Beginn |
---|---|---|
AETERNA ZENTARIS INC. | Director of Finance/CFO | 24.01.2022 |
Ehemalige bekannte Positionen von Giuliano La Fratta
Unternehmen | Position | Ende |
---|---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - |
Ausbildung von Giuliano La Fratta
Concordia University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AETERNA ZENTARIS INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |